A large trial of COVID-19 positive patients at increased risk of severe illness showed that two types of monoclonal antibody infusions did reduce the severity of their infection compared to controls.
How has COVID-19 affected mental health in the US? A representative study shows how and why the pandemic had such an impact, which will help develop better public health approaches to future long-term crises.
So far, it seems that the mRNA vaccine platform does not produce many side effects in pregnant women. It passes some immunoglobulins to the fetus, but it is unknown if the fetus develops robust immunity.
Researchers from Australia have confirmed that an FDA-approved anti-parasitic agent called Ivermectin can inhibit SARS-Cov2 replication in the cell and have proposed it as a candidate for further clinical trials.
Scientists recently discovered key information about SARS-CoV-2 that could improve the medical treatment of patients with severe pneumonia.
Questions surrounding the nature of asymptomatic cases of coronavirus disease 2019 (COVID-19) have been present since near the beginning of the pandemic. A recent meta-analysis explored what has been published on this question.
Do commercial hand sanitizers work on coronavirus? In the lab, yes. Studies are needed using real human hands, which come with ethical challenges.
A potential way to speed up vaccine development: human challenge trials. #covid19 #research
Obesity and abnormal liver function have been predicted to play a part in extended hospitalization duration and worsen the health conditions of COVID-19 patients.
Nationwide study reveals the deadly impact of the coronavirus on cancer patients In a study of 2,000 cancer patients, hydroxychloroquine showed no clinical benefit. Remdesivir was associated with a lower mortality risk but only certain groups of patients had access to it. Cancer patients also showed a higher risk of dying within 30 days of receiving a coronavirus diagnosis.
In a study of 2,000 cancer patients, hydroxychloroquine showed no clinical benefit. Remdesivir was associated with a lower mortality risk but only certain groups of patients had access to it. Cancer patients also showed a higher risk of dying within 30 Days of receiving a coronavirus diagnosis.